* National Health Investors Inc NHI.N NHI is expected
to show
a rise in quarterly revenue when it reports results on November
7.
* The Murfreesboro Tennessee-based company is expected to
report
a 1.8% increase in revenue to $77.689 million from $76.3 million
a year ago, according to the mean estimate from 4 analysts,
based on LSEG data.
* Refinitiv's mean analyst estimate for National Health
Investors
Inc is for earnings of 72 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 8
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for National
Health
Investors Inc is $54, above its last closing price of $51.44.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 1.08 1.08 1.06 Missed -2.3
Mar. 31 2023 0.99 1.00 1.11 Beat 11.4
Dec. 31 2022 1.09 1.09 0.85 Missed -22.2
Sep. 30 2022 1.06 1.07 1.06 Missed -0.6
Jun. 1.21 1.21 1.26 Beat 4.4
30 2022
Mar. 31 2022 1.13 1.10 1.10 Met -0.2
Dec. 31 2021 1.09 1.11 1.06 Missed -4.7
Sep. 30 2021 1.18 1.22 1.15 Missed -5.4
This summary was machine generated November 4 at 03:02 GMT. All
figures in US dollars unless otherwise stated